These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3601317)

  • 21. A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma.
    Balch CM; Soong SJ; Murad TM; Ingalls AL; Maddox WA
    Surgery; 1979 Aug; 86(2):343-51. PubMed ID: 462379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of malignant melanoma.
    Kroon BB; Nieweg OE
    Ann Chir Gynaecol; 2000; 89(3):242-50. PubMed ID: 11079795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymph node assessment in melanoma.
    Easson AM; Rotstein LE; McCready DR
    J Surg Oncol; 2009 Mar; 99(4):176-85. PubMed ID: 19065639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of patients with intermediate-thickness melanoma.
    Urist MM
    Annu Rev Med; 1996; 47():211-7. PubMed ID: 8712776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Consensus conference. Follow-up of patients surgically treated for stage I melanoma].
    Ann Dermatol Venereol; 1995; 122(5):250-8. PubMed ID: 8572461
    [No Abstract]   [Full Text] [Related]  

  • 26. [Evaluation of prognostic factors in malignant melanoma according to the actuarial method: report of 75 cases (author's transl)].
    Pelletier N; Claudy A; Thivolet J
    Dermatologica; 1978; 157(4):210-20. PubMed ID: 689232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognosis in Stage 1 malignant melanoma: seven-year follow-up study of splenic radiocolloid uptake as predictor of death.
    Koh HK; Sober AJ; Kopf A; Day CL; McKusick KA; Lew RA; Fitzpatrick TB
    J Nucl Med; 1984 Nov; 25(11):1183-9. PubMed ID: 6491749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The new melanoma staging system.
    Kim CJ; Reintgen DS; Balch CM;
    Cancer Control; 2002; 9(1):9-15. PubMed ID: 11907461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prognosis of malignant melanoma following dissection regional lymph node metastases].
    Sprakel B; Stenschke F; Unnewehr M; Ladas A; Senninger N
    Chirurg; 2003 Jan; 74(1):55-60. PubMed ID: 12552406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of early-stage cutaneous melanoma.
    Aloia TA; Gershenwald JE
    Curr Probl Surg; 2005 Jul; 42(7):460-534. PubMed ID: 16099230
    [No Abstract]   [Full Text] [Related]  

  • 31. Sentinel lymph node biopsy for melanoma: one procedure but many questions: comment on "Prognostic usefulness of sentinel lymph node biopsy for patients who have clinically node negative, localized, primary invasive cutaneous melanoma".
    Wong SL; Sabel MS; Johnson TM
    Arch Dermatol; 2011 Apr; 147(4):415-6. PubMed ID: 21482891
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-term survival in stage I and stage II malignant melanoma of the limbs--a regional review.
    Weaver RM; Grimley RP
    Clin Oncol; 1983 Jun; 9(2):131-4. PubMed ID: 6883839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sentinel node mapping for melanoma: results of trials and current applications.
    Thompson JF; Shaw HM
    Surg Oncol Clin N Am; 2007 Jan; 16(1):35-54. PubMed ID: 17336235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998.
    Fisher SR
    Laryngoscope; 2002 Jan; 112(1):99-110. PubMed ID: 11802046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical management of cutaneous melanoma: current practice and impact on prognosis.
    Mosca PJ; Tyler DS; Seigler HF
    Adv Surg; 2004; 38():85-119. PubMed ID: 15515616
    [No Abstract]   [Full Text] [Related]  

  • 36. The significance of melanoma micrometastases in the sentinel lymph node.
    Giblin AV; Hayes AJ; Thomas JM
    Eur J Surg Oncol; 2005 Dec; 31(10):1103-4. PubMed ID: 16084052
    [No Abstract]   [Full Text] [Related]  

  • 37. Prognostic variables for patients with stage III malignant melanoma.
    Messaris GE; Konstadoulakis MM; Ricaniadis N; Leandros E; Androulakis G; Karakousis PC
    Eur J Surg; 2000 Mar; 166(3):233-9. PubMed ID: 10755339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sentinel lymph node dissection in patients with malignant melanoma. Diagnostic and therapeutic standards].
    Arens A; Osinga J; Schwipper V; Schober O; Tilkorn H; Liebau J
    Chirurg; 2003 Jul; 74(7):665-70. PubMed ID: 12883795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Relation between the prognosis of skin melanomas and the timing of appearance of regional metastases].
    Vagner RI; Anisimov VV
    Vopr Onkol; 1986; 32(10):21-5. PubMed ID: 3776125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors for melanoma.
    Wisco OJ; Sober AJ
    Dermatol Clin; 2012 Jul; 30(3):469-85. PubMed ID: 22800552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.